USPTO serial 87469889
DISCOVERY SQUARE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- DIBLE, JONATHON I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DISCOVERY SQUARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Destination Medical Center Corporation
Rochester, MN
Other trademarks owned by Destination Medical Center Corporation
Destination Medical Center Corporation
Rochester, MN
Other trademarks owned by Destination Medical Center Corporation
Destination Medical Center Corporation
Rochester, MN
Other trademarks owned by Destination Medical Center Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth C. Buckingham
Elizabeth C. Buckingham DORSEY & WHITNEY LLP50 SOUTH SIXTH STREETSUITE 1500MINNEAPOLIS, MN 55402-1498Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business services, namely, promoting collaboration within the medical, scientific, and research communities to achieve advances in the fields of translational scientific and biomedical research; providing information in the fields of business innovation process, business management, and business opportunities management; consulting and advisory services in the areas of business growth strategy, innovation and growth processes, organizational transformation, and talent management and development strategies; business management services, namely, acquisition, sale, and licensing of intellectual property rights of others; obtaining and managing external funding, grants, contracts, fellowships, and awards in support of research, training, and educational outreach programs; promoting public awareness of the benefits of collaboration and innovation within the translational scientific and biomedical research communities; incubation, acceleration, and support services, namely, providing work space containing business equipment to individuals, start-up businesses, existing businesses, non-profit organizations, and governmental organizations | ACTIVE | Jan 15, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Destination Medical Center Corporation
- Other trademarks owned by Destination Medical Center Corporation
- Other trademarks owned by Destination Medical Center Corporation
- Other trademarks in Class 035
- Similar marks named DISCOVERY SQUARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 20, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 19, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 17, 2020 | IUAF | USE AMENDMENT FILED | — |
| Dec 17, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 20, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 19, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 19, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 3, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 3, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2019 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 4, 2019 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 15, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 13, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 13, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 13, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 4, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 4, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 2, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 31, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 31, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 31, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 19, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 24, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 18, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 1, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |